EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Integrated Infectious Disease and Substance Use Disorder Care for the Treatment of Injection Drug Use–Associated Infections: A Prospective Cohort Study With Historical Control

David P Serota iD, Liza Rosenbloom, Belén Hervera, Grace Seo, Daniel J Feaster, Lisa R Metsch, Edward Suarez, Teresa A Chueng, Salma Hernandez, Allan E Rodriguez, Hansel E Tookes, Susanne Doblecki-Lewis und 1 weitere

Open Forum Infectious Diseases · 04.01.2023 · 10 (1)

DOI: 10.1093/ofid/ofac688 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 21.12.2022. Verfasst von David P Serota und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDA NIH HHS, Miami Center for AIDS Research, University of Miami.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To address the infectious disease (ID) and substance use disorder (SUD) syndemic, we developed an integrated ID/SUD clinical team rooted in harm reduction at a county hospital in Miami, Florida. The Severe Injection-Related Infection (SIRI) team treats people who inject drugs (PWID) and provides medical care, SUD treatment, and patient navigation during hospitalization and after hospital discharge. We assessed the impact of the SIRI team on ID and SUD treatment and healthcare utilization outcomes.

Methods

We prospectively collected data on patients seen by the SIRI team. A diagnostic code algorithm confirmed by chart review was used to identify a historical control group of patients with SIRI hospitalizations in the year preceding implementation of the SIRI team. The primary outcome was death or readmission within 90 days post–hospital discharge. Secondary outcomes included initiation of medications for opioid use disorder (MOUD) and antibiotic course completion.

Results

There were 129 patients included in the study: 59 in the SIRI team intervention and 70 in the pre-SIRI team control group. SIRI team patients had a 45% risk reduction (aRR, 0.55 [95% confidence interval CI, .32–.95]; 24% vs 44%) of being readmitted in 90 days or dying compared to pre-SIRI historical controls. SIRI team patients were more likely to initiate MOUD in the hospital (93% vs 33%, P < .01), complete antibiotic treatment (90% vs 60%, P < .01), and less likely to have patient-directed discharge (17% vs 37%, P = .02).

Conclusions

An integrated ID/SUD team was associated with improvements in healthcare utilization, MOUD initiation, and antibiotic completion for PWID with infections.

Schlagwörter

Stichwörter der Autor:innen

buprenorphineinjection drug useinjection-related infectionopioid use disordersubstance use disorder

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Division of Biostatistics, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, New York, USA.
  • Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Division of Health Services Research and Policy, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida, USA.

ORCID-Profile: David P Serota, Tyler S Bartholomew

Förderung

  • NIDA NIH HHS
  • Miami Center for AIDS Research
  • University of Miami
  • Miller School of Medicine
  • NIH
  • following NIH co-funding
  • National
  • Institute of Allergy and Infectious Diseases

Zitieren

APA

Serota, D. P., Rosenbloom, L., Hervera, B., Seo, G., Feaster, D. J., Metsch, L. R., Suarez, E., Chueng, T. A., Hernandez, S., Rodriguez, A. E., Tookes, H. E., Doblecki-Lewis, S., & Bartholomew, T. S. (2023). Integrated Infectious Disease and Substance Use Disorder Care for the Treatment of Injection Drug Use–Associated Infections: A Prospective Cohort Study With Historical Control. Open Forum Infectious Diseases, 10(1). https://doi.org/10.1093/ofid/ofac688

Vancouver

Serota DP, Rosenbloom L, Hervera B, Seo G, Feaster DJ, Metsch LR, et al. Integrated Infectious Disease and Substance Use Disorder Care for the Treatment of Injection Drug Use–Associated Infections: A Prospective Cohort Study With Historical Control. Open Forum Infectious Diseases. 2023;10(1). doi:10.1093/ofid/ofac688

BibTeX
@article{Serota2023,
  author = {Serota, David P and Rosenbloom, Liza and Hervera, Belén and Seo, Grace and Feaster, Daniel J and Metsch, Lisa R and Suarez, Edward and Chueng, Teresa A and Hernandez, Salma and Rodriguez, Allan E and Tookes, Hansel E and Doblecki-Lewis, Susanne and Bartholomew, Tyler S},
  title = {Integrated Infectious Disease and Substance Use Disorder Care for the Treatment of Injection Drug Use–Associated Infections: A Prospective Cohort Study With Historical Control},
  journal = {Open Forum Infectious Diseases},
  year = {2023},
  volume = {10},
  number = {1},
  doi = {10.1093/ofid/ofac688}
}
Kostenlos starten →